309) paRG did not activate PXR in the reporter gene assay, illustrating the limitations o |
310) ) HepaRG cells, as well as a PXR reporter gene assay, were used to investigate the m |
311) All those who took part had changes in a gene called ALK, which is involved in cell |
312) a certain resistance mutation in the EGFR gene, called T790M. |
313) Paralogs of the Obp50 gene cluster are expressed in metabolic an |
314) 3 (rs10735079, P = 1.65 × 10-8) in a gene cluster that encodes antiviral restri |
315) As expected, MSN-PEG possessed excellent gene delivery capacity with good binding, |
316) Among the current gene delivery carriers, cell-derived extra |
317) h after transfection, luciferase reporter gene detection kit was used to detect the |
318) rase were detected by luciferase reporter gene detection kit, and the ratio of the t |
319) role of RNA modifications in fine-tuning gene expressions at several levels has bee |
320) RNAs (lncRNAs), have been ascertained in gene expressions. |
321) e (HSC-3) with homozygous deletion of the gene for cathepsin S (CTSS) with CRISPR/Ca |
322) and brain-targeted delivery of the pApoE2 gene for effective AD therapy. |
323) th DAC induced the conversion of the FBW7 gene from a methylated form to an unmethyl |
324) mers to amplify the Acanthamoeba 18S-rRNA gene from mouse ocular tissue. |
325) n, allele variants of GPCRs, pseudogenes, gene fusion, and gene dosage, contribute t |
326) f GPCRs, uniparental disomy, pseudogenes, gene fusion, and gene dosage, need to be e |
327) Genetic variants in the SLCO1B1 gene have been associated with altered pro |
328) binding protein C (encoded by the MYBPC3 gene) have been associated with hypertroph |
329) oss of function in both copies of the RB1 gene is the causal mutation of retinoblast |
330) The SorLA protein, encoded by the SORL1 gene, is a major player in Alzheimer's dis |
331) erature and used GeneMANIA to investigate gene ontologies and predicted protein-inte |
332) Pathway analysis identified 15 gene ontologies that were differentially a |
333) nd lentiviral vector therapy to deliver a gene or secretory protein); 2. |
334) utosomal recessive variants in the CYB5R3 gene or to autosomal dominant variants in |
335) , particularly one-carbon metabolites, on gene pathways and neurodevelopment. |
336) Expression differences in gene pathways related to the immune system |
337) and primary DPCs group; the variation of gene profile data of more than 90% of DPCs |
338) is diagnostically helpful as the mutated gene profile is shared between the convent |
339) ven Cre (dLckCre) in which the distal Lck gene promoter drives Cre expression in the |
340) ntributing to the activation of the grp78 gene promoter. |
341) Multi-gene sequencing identified a species of at |
|